(2R,3R,4R,5R)-5-(4-Benzamido-2-oxopyrimidin-1(2H)-yl)-2-((benzoyloxy)methyl)-4-fluoro-4-methyltetrahydrofuran-3-yl benzoate
98%
- Product Code: 73939
CAS:
817204-32-3
| Molecular Weight: | 571.55 g./mol | Molecular Formula: | C₃₁H₂₆FN₃O₇ |
|---|---|---|---|
| EC Number: | MDL Number: | MFCD23106344 | |
| Melting Point: | Boiling Point: | ||
| Density: | Storage Condition: | -20°C, dry sealed |
Product Description:
This compound is primarily utilized in the field of medicinal chemistry and drug development, particularly in the synthesis of nucleoside analogs. These analogs are critical in the creation of antiviral and anticancer agents, as they can interfere with the replication of viral DNA or RNA, or inhibit the growth of cancer cells. The presence of the benzamido and benzoyl groups in its structure enhances its stability and bioavailability, making it a valuable intermediate in the production of therapeutic drugs. Additionally, its fluorinated tetrahydrofuran moiety contributes to its potential use in targeted therapies, where fluorine atoms are often incorporated to improve binding affinity and metabolic stability. Researchers also explore its application in the development of prodrugs, which are designed to release active pharmaceutical ingredients in a controlled manner within the body.
Product Specification:
| Test | Specification |
|---|---|
| APPEARANCE | White to off-white Solid |
| PURITY | 97.5-100 |
| Infrared spectrum | Conforms to Structure |
| NMR | Conforms to Structure |
Sizes / Availability / Pricing:
| Size (g) | Availability | Price | Quantity |
|---|---|---|---|
| 1.000 | 10-20 days | $23.10 |
+
-
|
| 5.000 | 10-20 days | $64.29 |
+
-
|
| 10.000 | 10-20 days | $114.52 |
+
-
|
| 25.000 | 10-20 days | $282.27 |
+
-
|
(2R,3R,4R,5R)-5-(4-Benzamido-2-oxopyrimidin-1(2H)-yl)-2-((benzoyloxy)methyl)-4-fluoro-4-methyltetrahydrofuran-3-yl benzoate
This compound is primarily utilized in the field of medicinal chemistry and drug development, particularly in the synthesis of nucleoside analogs. These analogs are critical in the creation of antiviral and anticancer agents, as they can interfere with the replication of viral DNA or RNA, or inhibit the growth of cancer cells. The presence of the benzamido and benzoyl groups in its structure enhances its stability and bioavailability, making it a valuable intermediate in the production of therapeutic drugs. Additionally, its fluorinated tetrahydrofuran moiety contributes to its potential use in targeted therapies, where fluorine atoms are often incorporated to improve binding affinity and metabolic stability. Researchers also explore its application in the development of prodrugs, which are designed to release active pharmaceutical ingredients in a controlled manner within the body.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Cart
No products
Subtotal:
$0.00
$0.00
Total :